Horizon Kinetics Medical ETF Rating → Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad) Free MEDX Stock Alerts $28.48 -0.17 (-0.59%) (As of 05/8/2024 ET) Add Compare Share Share RatingsStock AnalysisChartDividendHoldingsRatingsSocial MediaStock AnalysisChartDividendHoldingsRatingsSocial Media Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MEDX Aggregate RatingModerate Buy2.59Holdings in MEDX have an aggregate rating of Moderate Buy based on 342 analyst ratings issued in the past year covering 32 companies (88.5% of the portfolio).MEDX Aggregate Price Target$37.8933.06% UpsideHigh Prediction$50.49Average Prediction$37.89Low Prediction$26.34Holdings in MEDX have an aggregate price target of $37.89 and a range of $26.34 to $50.49 covering 32 companies (88.5% of the portfolio).MEDX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce0 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Horizon Kinetics Medical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 32 MEDX Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings15.09%LLYEli Lilly and Company$779.84+0.6%5 of 5 stars2.84$757.95 -2.8%19Earnings ReportDividend Announcement7.84%ABBVAbbVie$160.89+0.3%4 of 5 stars2.77$174.31 8.3%13Earnings Report5.53%AMGNAmgen$307.11-0.1%5 of 5 stars2.52$305.05 -0.7%21Earnings ReportAnalyst ForecastAnalyst Revision5.32%AZNAstraZeneca$77.13+0.2%2 of 5 stars2.57$81.00 5.0%75.24%BMYBristol-Myers Squibb$43.59-0.2%5 of 5 stars2.11$60.00 37.6%195.19%JNJJohnson & Johnson$149.57+0.4%5 of 5 stars2.46$175.86 17.6%13Analyst ForecastAnalyst Revision5.13%MRKMerck & Co., Inc.$129.500.0%5 of 5 stars2.58$131.33 1.4%124.11%PFEPfizer$27.41-1.6%5 of 5 stars2.38$36.00 31.3%16Options VolumeAnalyst Revision3.93%REGNRegeneron Pharmaceuticals$958.06+0.2%4 of 5 stars2.70$981.71 2.5%203.63%BIIBBiogen$219.74+0.0%5 of 5 stars2.65$290.92 32.4%263.59%CRSPCRISPR Therapeutics$52.15-2.1%3 of 5 stars2.38$77.23 48.1%17Upcoming EarningsAnalyst ForecastGap Down3.37%ALKSAlkermes$24.34+1.0%5 of 5 stars2.50$35.38 45.3%10Analyst Revision3.14%IONSIonis Pharmaceuticals$39.93-0.6%4 of 5 stars2.71$59.54 49.1%14Earnings ReportAnalyst ForecastInsider SellingNews CoveragePositive News2.80%GSKGSK$44.41+0.6%3 of 5 stars2.4052.53%ALNYAlnylam Pharmaceuticals$151.34-0.6%5 of 5 stars2.59$216.19 42.8%17Earnings ReportAnalyst Forecast1.97%BCYCBicycle Therapeutics$23.72+0.4%1 of 5 stars2.86$46.86 97.5%7Earnings Report1.87%NTLAIntellia Therapeutics$23.89+3.9%4 of 5 stars2.69$67.00 180.5%13Gap Up1.36%BEAMBeam Therapeutics$22.29+0.2%2 of 5 stars2.38$41.00 83.9%13Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.09%GALTGalectin Therapeutics$3.34+3.1%1 of 5 stars3.00$11.00 229.3%11.04%EDITEditas Medicine$5.31+5.4%3 of 5 stars2.56$15.00 182.5%10Analyst UpgradeNews CoverageGap Down1.00%LTRNLantern Pharma$6.50+0.3%0 of 5 stars2.0010.71%HLNHaleon$8.27+1.0%3 of 5 stars2.6050.56%REPLReplimune Group$6.67-0.1%4 of 5 stars3.00$37.67 464.7%3Upcoming Earnings0.50%GEHCGE HealthCare Technologies$81.77+0.8%4 of 5 stars2.64$95.00 16.2%11Gap Down0.48%TSVT2seventy bio$4.39-2.0%2 of 5 stars2.38$13.17 199.9%8News Coverage0.39%ALLOAllogene Therapeutics$2.82+2.2%2 of 5 stars2.71$13.50 378.7%7Upcoming Earnings0.39%SDZNYSandoz Group$34.60+4.2%1 of 5 stars3.003Gap Up0.24%VTRSViatris$11.58-1.9%1 of 5 stars1.33$11.00 -5.0%3News Coverage0.21%BLUEbluebird bio$1.05+7.7%2 of 5 stars2.27$5.74 447.1%11Upcoming Earnings0.10%PACBPacific Biosciences of California$1.70+1.2%4 of 5 stars2.53$7.77 357.2%15Gap Down0.09%SLRXSalarius Pharmaceuticals$0.47-3.5%0 of 5 stars2.001Gap Up0.05%MURAMural Oncology$3.87-0.5%2 of 5 stars3.00$13.00 235.9%1 This page (NASDAQ:MEDX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Horizon Kinetics Medical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
